Literature DB >> 29622555

MRI Planimetry and Magnetic Resonance Parkinsonism Index in the Differential Diagnosis of Patients with Parkinsonism.

V C Constantinides1, G P Paraskevas2, G Velonakis3, P Toulas3, E Stamboulis2, E Kapaki2.   

Abstract

BACKGROUND AND
PURPOSE: Differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration from Parkinson disease on clinical grounds is often difficult. MR imaging biomarkers could assist in a more accurate diagnosis. We examined the utility of MR imaging surface measurements (MR imaging planimetry) in the differential diagnosis of patients with parkinsonism.
MATERIALS AND METHODS: Fifty-two patients with Parkinson-plus (progressive supranuclear palsy, n = 24; corticobasal degeneration, n = 9; multiple system atrophy, n = 19), 18 patients with Parkinson disease, and 15 healthy controls were included. Corpus callosum, midbrain, and pons surfaces; relevant indices; and the Magnetic Resonance Parkinsonism Index were calculated. Corpus callosum subsection analysis was performed, and the corpus callosum posteroanterior gradient was introduced.
RESULTS: A Magnetic Resonance Parkinsonism Index value of >12.6 discriminated progressive supranuclear palsy from other causes of parkinsonism with a 91% sensitivity and 95% specificity. No planimetry measurement could accurately discriminate those with multiple system atrophy with parkinsonism from patients with Parkinson disease. A corpus callosum posteroanterior gradient value of ≤191 was highly specific (97%) and moderately sensitive (75%) for the diagnosis of corticobasal degeneration versus all other groups. A midbrain-to-corpus callosum posteroanterior gradient ratio of ≤0.45 was highly indicative of progressive supranuclear palsy over corticobasal degeneration (sensitivity 86%, specificity 88%).
CONCLUSIONS: MR imaging planimetry measurements are potent imaging markers of progressive supranuclear palsy and promising markers of corticobasal degeneration but do not seem to assist in the diagnosis of multiple system atrophy with parkinsonism.
© 2018 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2018        PMID: 29622555      PMCID: PMC7410639          DOI: 10.3174/ajnr.A5618

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  29 in total

1.  MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.

Authors:  Giulia Longoni; Federica Agosta; Vladimir S Kostić; Tanja Stojković; Elisabetta Pagani; Tatjana Stošić-Opinćal; Massimo Filippi
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

2.  Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia.

Authors:  George P Paraskevas; Dimitrios Kasselimis; Evie Kourtidou; Vasilios Constantinides; Anastasia Bougea; Costas Potagas; Ioannis Evdokimidis; Elisabeth Kapaki
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 3.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Authors:  I Litvan; Y Agid; D Calne; G Campbell; B Dubois; R C Duvoisin; C G Goetz; L I Golbe; J Grafman; J H Growdon; M Hallett; J Jankovic; N P Quinn; E Tolosa; D S Zee
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

4.  Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy.

Authors:  H Yamauchi; H Fukuyama; Y Nagahama; Y Katsumi; Y Dong; J Konishi; J Kimura
Journal:  Ann Neurol       Date:  1997-05       Impact factor: 10.422

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Multiple system atrophy: a review of 203 pathologically proven cases.

Authors:  G K Wenning; F Tison; Y Ben Shlomo; S E Daniel; N P Quinn
Journal:  Mov Disord       Date:  1997-03       Impact factor: 10.338

7.  MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.

Authors:  Aldo Quattrone; Giuseppe Nicoletti; Demetrio Messina; Francesco Fera; Francesca Condino; Pierfrancesco Pugliese; Pierluigi Lanza; Paolo Barone; Letterio Morgante; Mario Zappia; Umberto Aguglia; Olivier Gallo
Journal:  Radiology       Date:  2007-11-08       Impact factor: 11.105

8.  The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy.

Authors:  Luke A Massey; Hans R Jäger; Dominic C Paviour; Sean S O'Sullivan; Helen Ling; David R Williams; Constantinos Kallis; Janice Holton; Tamas Revesz; David J Burn; Tarek Yousry; Andrew J Lees; Nick C Fox; Caroline Micallef
Journal:  Neurology       Date:  2013-04-24       Impact factor: 9.910

9.  Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging.

Authors:  M Cosottini; R Ceravolo; L Faggioni; G Lazzarotti; M C Michelassi; U Bonuccelli; L Murri; C Bartolozzi
Journal:  Acta Neurol Scand       Date:  2007-07       Impact factor: 3.209

10.  Utility of the Midbrain Tegmentum Diameter in the Differential Diagnosis of Progressive Supranuclear Palsy from Idiopathic Parkinson's Disease.

Authors:  Yool Hee Kim; Hyeo Il Ma; Yun Joong Kim
Journal:  J Clin Neurol       Date:  2015-07       Impact factor: 3.077

View more
  6 in total

1.  Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study.

Authors:  Salvatore Nigro; Angelo Antonini; David E Vaillancourt; Klaus Seppi; Roberto Ceravolo; Antonio P Strafella; Antonio Augimeri; Andrea Quattrone; Maurizio Morelli; Luca Weis; Eleonora Fiorenzato; Roberta Biundo; Roxana G Burciu; Florian Krismer; Nikolaus R McFarland; Christoph Mueller; Elke R Gizewski; Mirco Cosottini; Eleonora Del Prete; Sonia Mazzucchi; Aldo Quattrone
Journal:  Mov Disord       Date:  2020-02-24       Impact factor: 10.338

2.  Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology.

Authors:  Daniel Richter; Aristeidis H Katsanos; Christoph Schroeder; Georgios Tsivgoulis; George P Paraskevas; Thomas Müller; Andrei V Alexandrov; Ralf Gold; Lars Tönges; Christos Krogias
Journal:  Cells       Date:  2019-12-18       Impact factor: 6.600

3.  Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease.

Authors:  Andrea Quattrone; Maria G Bianco; Angelo Antonini; David E Vaillancourt; Klaus Seppi; Roberto Ceravolo; Antonio P Strafella; Gioacchino Tedeschi; Alessandro Tessitore; Roberto Cilia; Maurizio Morelli; Salvatore Nigro; Basilio Vescio; Pier Paolo Arcuri; Rosa De Micco; Mario Cirillo; Luca Weis; Eleonora Fiorenzato; Roberta Biundo; Roxana G Burciu; Florian Krismer; Nikolaus R McFarland; Christoph Mueller; Elke R Gizewski; Mirco Cosottini; Eleonora Del Prete; Sonia Mazzucchi; Aldo Quattrone
Journal:  Mov Disord       Date:  2022-04-11       Impact factor: 9.698

4.  Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism.

Authors:  Derek B Archer; Trina Mitchell; Roxana G Burciu; Jing Yang; Salvatore Nigro; Aldo Quattrone; Andrea Quattrone; Andreas Jeromin; Nikolaus R McFarland; Michael S Okun; David E Vaillancourt
Journal:  Mov Disord       Date:  2020-05-01       Impact factor: 10.338

5.  Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.

Authors:  Hirotaka Sakuramoto; Hiroaki Fujita; Keisuke Suzuki; Takeo Matsubara; Yuji Watanabe; Mai Hamaguchi; Koichi Hirata
Journal:  Clin Park Relat Disord       Date:  2019-12-11

6.  Diagnostic Performance of the Magnetic Resonance Parkinsonism Index in Differentiating Progressive Supranuclear Palsy from Parkinson's Disease: An Updated Systematic Review and Meta-Analysis.

Authors:  Seongken Kim; Chong Hyun Suh; Woo Hyun Shim; Sang Joon Kim
Journal:  Diagnostics (Basel)       Date:  2021-12-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.